APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Atovaquone and Proguanil

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Atovaquone and Proguanil Industry Growth and Trends Forecast to 2032

Report ID 173968060120 December 202574 pages

Choose your research edition.

Industry ResearchAtovaquone and Proguanil Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Atovaquone and Proguanil Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atovaquone and Proguanil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atovaquone and Proguanil Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Atovaquone and Proguanil Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Atovaquone and Proguanil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atovaquone and Proguanil include GSK, Mylan Pharmaceuticals, Hetero and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Atovaquone and Proguanil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Atovaquone and Proguanil market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Atovaquone and Proguanil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Atovaquone and Proguanil.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Atovaquone and Proguanil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Atovaquone and Proguanil Market by Company

GSK

Mylan Pharmaceuticals

Hetero

Glenmark

Atovaquone and Proguanil Segment by Type

250 mg/100 mg

62.5mg/25mg

Atovaquone and Proguanil Segment by Application

Adult

Paediatric

Atovaquone and Proguanil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atovaquone and Proguanil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atovaquone and Proguanil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atovaquone and Proguanil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Atovaquone and Proguanil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 250 mg/100 mg Table 2. Major Company of 62.5mg/25mg Table 3. Global Atovaquone and Proguanil Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 5. Global Atovaquone and Proguanil Sales Market Share in Volume by Type (2021-2026) Table 6. Global Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 7. Global Atovaquone and Proguanil Sales Market Share in Value by Type (2021-2026) Table 8. Global Atovaquone and Proguanil Price by Type (2021-2026) & (US$/Unit) Table 9. Global Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 10. Global Atovaquone and Proguanil Sales Market Share in Volume by Type (2027-2032) Table 11. Global Atovaquone and Proguanil Sales by Type (2027-2032) & (US$ Million) Table 12. Global Atovaquone and Proguanil Sales Market Share in Value by Type (2027-2032) Table 13. Global Atovaquone and Proguanil Price by Type (2027-2032) & (US$/Unit) Table 14. North America Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 15. North America Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 17. Europe Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 21. Latin America Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Atovaquone and Proguanil Sales by Type (2021-2026) & (US$ Million) Table 24. Atovaquone and Proguanil Industry Trends Table 25. Atovaquone and Proguanil Industry Drivers Table 26. Atovaquone and Proguanil Industry Opportunities and Challenges Table 27. Atovaquone and Proguanil Industry Restraints Table 28. Global Atovaquone and Proguanil Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Atovaquone and Proguanil Revenue Market Share by Company (2021-2026) Table 30. Global Atovaquone and Proguanil Sales by Company (2021-2026) & (W Units) Table 31. Global Atovaquone and Proguanil Sales Share by Company (2021-2026) Table 32. Global Atovaquone and Proguanil Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Atovaquone and Proguanil Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Atovaquone and Proguanil Major Company Production Sites and Headquarters Table 35. Global Atovaquone and Proguanil Company, Product Type & Application Table 36. Global Atovaquone and Proguanil Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Atovaquone and Proguanil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Atovaquone and Proguanil Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Atovaquone and Proguanil Sales by Region (2021-2026) & (W Units) Table 41. Global Atovaquone and Proguanil Sales Market Share in Volume by Region (2021-2026) Table 42. Global Atovaquone and Proguanil Sales by Region (2021-2026) & (US$ Million) Table 43. Global Atovaquone and Proguanil Sales Market Share in Value by Region (2021-2026) Table 44. Global Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Atovaquone and Proguanil Sales by Region (2027-2032) & (W Units) Table 46. Global Atovaquone and Proguanil Sales Market Share in Volume by Region (2027-2032) Table 47. Global Atovaquone and Proguanil Sales by Region (2027-2032) & (US$ Million) Table 48. Global Atovaquone and Proguanil Sales Market Share in Value by Region (2027-2032) Table 49. Global Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Atovaquone and Proguanil Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 52. Global Atovaquone and Proguanil Sales Market Share in Volume by Application (2021-2026) Table 53. Global Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 54. Global Atovaquone and Proguanil Sales Market Share in Value by Application (2021-2026) Table 55. Global Atovaquone and Proguanil Price by Application (2021-2026) & (US$/Unit) Table 56. Global Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 57. Global Atovaquone and Proguanil Sales Market Share in Volume by Application (2027-2032) Table 58. Global Atovaquone and Proguanil Sales by Application (2027-2032) & (US$ Million) Table 59. Global Atovaquone and Proguanil Sales Market Share in Value by Application (2027-2032) Table 60. Global Atovaquone and Proguanil Price by Application (2027-2032) & (US$/Unit) Table 61. North America Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 62. North America Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 64. Europe Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 68. Latin America Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Atovaquone and Proguanil Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Atovaquone and Proguanil Product Portfolio Table 75. GSK Recent Development Table 76. Mylan Pharmaceuticals Company Information Table 77. Mylan Pharmaceuticals Business Overview Table 78. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio Table 80. Mylan Pharmaceuticals Recent Development Table 81. Hetero Company Information Table 82. Hetero Business Overview Table 83. Hetero Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hetero Atovaquone and Proguanil Product Portfolio Table 85. Hetero Recent Development Table 86. Glenmark Company Information Table 87. Glenmark Business Overview Table 88. Glenmark Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Glenmark Atovaquone and Proguanil Product Portfolio Table 90. Glenmark Recent Development Table 91. North America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 92. North America Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 93. North America Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 94. North America Atovaquone and Proguanil Sales Forecast by Country (2027-2032) & (W Units) Table 95. North America Atovaquone and Proguanil Sales Market Share Forecast by Country (2027-2032) Table 96. North America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Atovaquone and Proguanil Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Atovaquone and Proguanil Market Share by Country (2021-2026) Table 99. North America Atovaquone and Proguanil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Atovaquone and Proguanil Market Share Forecast by Country (2027-2032) Table 101. Europe Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 102. Europe Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 103. Europe Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 104. Europe Atovaquone and Proguanil Sales Forecast by Country (2027-2032) & (W Units) Table 105. Europe Atovaquone and Proguanil Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Atovaquone and Proguanil Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Atovaquone and Proguanil Market Share by Country (2021-2026) Table 109. Europe Atovaquone and Proguanil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Atovaquone and Proguanil Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 113. Asia-Pacific Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Atovaquone and Proguanil Sales Forecast by Country (2027-2032) & (W Units) Table 115. Asia-Pacific Atovaquone and Proguanil Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Atovaquone and Proguanil Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Atovaquone and Proguanil Market Share by Country (2021-2026) Table 119. Asia-Pacific Atovaquone and Proguanil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Atovaquone and Proguanil Market Share Forecast by Country (2027-2032) Table 121. Latin America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. Latin America Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 123. Latin America Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 124. Latin America Atovaquone and Proguanil Sales Forecast by Country (2027-2032) & (W Units) Table 125. Latin America Atovaquone and Proguanil Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Atovaquone and Proguanil Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Atovaquone and Proguanil Market Share by Country (2021-2026) Table 129. Latin America Atovaquone and Proguanil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Atovaquone and Proguanil Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 133. Middle East and Africa Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Atovaquone and Proguanil Sales Forecast by Country (2027-2032) & (W Units) Table 135. Middle East and Africa Atovaquone and Proguanil Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Atovaquone and Proguanil Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Atovaquone and Proguanil Market Share by Country (2021-2026) Table 139. Middle East and Africa Atovaquone and Proguanil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Atovaquone and Proguanil Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Atovaquone and Proguanil Distributors List Table 144. Atovaquone and Proguanil Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Atovaquone and Proguanil Image Figure 2. Global Atovaquone and Proguanil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atovaquone and Proguanil Market Size (2021-2032) & (US$ Million) Figure 4. Global Atovaquone and Proguanil Sales (2021-2032) & (W Units) Figure 5. 250 mg/100 mg Image Figure 6. Global 250 mg/100 mg Sales YoY Growth (2021-2032) & (W Units) Figure 7. 62.5mg/25mg Image Figure 8. Global 62.5mg/25mg Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Atovaquone and Proguanil Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Atovaquone and Proguanil Market Share by Type 2025 VS 2032 Figure 11. North America Atovaquone and Proguanil Sales Market Share in Volume by Type in 2025 Figure 12. North America Atovaquone and Proguanil Sales Market Share in Value by Type in 2025 Figure 13. Europe Atovaquone and Proguanil Sales Market Share in Volume by Type in 2025 Figure 14. Europe Atovaquone and Proguanil Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Atovaquone and Proguanil Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Atovaquone and Proguanil Sales Market Share in Value by Type in 2025 Figure 17. Latin America Atovaquone and Proguanil Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Atovaquone and Proguanil Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Atovaquone and Proguanil Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Atovaquone and Proguanil Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Atovaquone and Proguanil Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 25. Paediatric Image Figure 26. Global Paediatric Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Atovaquone and Proguanil Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Atovaquone and Proguanil Market Share by Application 2025 VS 2032 Figure 29. North America Atovaquone and Proguanil Sales Market Share in Volume by Application in 2025 Figure 30. North America Atovaquone and Proguanil Sales Market Share in Value by Application in 2025 Figure 31. Europe Atovaquone and Proguanil Sales Market Share in Volume by Application in 2025 Figure 32. Europe Atovaquone and Proguanil Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Atovaquone and Proguanil Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Atovaquone and Proguanil Sales Market Share in Value by Application in 2025 Figure 35. Latin America Atovaquone and Proguanil Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Atovaquone and Proguanil Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Atovaquone and Proguanil Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Atovaquone and Proguanil Sales Market Share in Value by Application in 2025 Figure 39. North America Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Atovaquone and Proguanil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Atovaquone and Proguanil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Atovaquone and Proguanil Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Atovaquone and Proguanil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Atovaquone and Proguanil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Atovaquone and Proguanil Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Atovaquone and Proguanil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Atovaquone and Proguanil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Atovaquone and Proguanil Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Atovaquone and Proguanil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Atovaquone and Proguanil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Atovaquone and Proguanil Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Atovaquone and Proguanil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Atovaquone and Proguanil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Atovaquone and Proguanil Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Atovaquone and Proguanil Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Atovaquone and Proguanil Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 250 mg/100 mg
  • 62.5mg/25mg
Applications
  • Adult
  • Paediatric
Companies covered
  • GSK
  • Mylan Pharmaceuticals
  • Hetero
  • Glenmark

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atovaquone and Proguanil Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Atovaquone and Proguanil Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Atovaquone and Proguanil Market by Type
  6. 1.3.1 250 mg/100 mg
  7. 1.3.2 62.5mg/25mg
  8. 1.4 Global Atovaquone and Proguanil Market Size by Type
  9. 1.4.1 Global Atovaquone and Proguanil Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Atovaquone and Proguanil Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Atovaquone and Proguanil Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Atovaquone and Proguanil Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Atovaquone and Proguanil Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Atovaquone and Proguanil Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Atovaquone and Proguanil Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Atovaquone and Proguanil Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Atovaquone and Proguanil Industry Trends
  2. 2.2 Atovaquone and Proguanil Industry Drivers
  3. 2.3 Atovaquone and Proguanil Industry Opportunities and Challenges
  4. 2.4 Atovaquone and Proguanil Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Atovaquone and Proguanil Revenue (2021-2026)
  2. 3.2 Global Top Players by Atovaquone and Proguanil Sales (2021-2026)
  3. 3.3 Global Top Players by Atovaquone and Proguanil Price (2021-2026)
  4. 3.4 Global Atovaquone and Proguanil Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atovaquone and Proguanil Major Company Production Sites & Headquarters
  6. 3.6 Global Atovaquone and Proguanil Company, Product Type & Application
  7. 3.7 Global Atovaquone and Proguanil Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atovaquone and Proguanil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atovaquone and Proguanil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atovaquone and Proguanil Tier 1, Tier 2, and Tier 3
4 Atovaquone and Proguanil Regional Status and Outlook
  1. 4.1 Global Atovaquone and Proguanil Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Atovaquone and Proguanil Historic Market Size by Region
  3. 4.2.1 Global Atovaquone and Proguanil Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Atovaquone and Proguanil Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Atovaquone and Proguanil Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Atovaquone and Proguanil Forecasted Market Size by Region
  7. 4.3.1 Global Atovaquone and Proguanil Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Atovaquone and Proguanil Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Atovaquone and Proguanil Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Atovaquone and Proguanil by Application
  1. 5.1 Atovaquone and Proguanil Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Paediatric
  4. 5.2 Global Atovaquone and Proguanil Market Size by Application
  5. 5.2.1 Global Atovaquone and Proguanil Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Atovaquone and Proguanil Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Atovaquone and Proguanil Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Atovaquone and Proguanil Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Atovaquone and Proguanil Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Atovaquone and Proguanil Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Atovaquone and Proguanil Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Atovaquone and Proguanil Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Atovaquone and Proguanil Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Mylan Pharmaceuticals
  8. 6.2.1 Mylan Pharmaceuticals Company Information
  9. 6.2.2 Mylan Pharmaceuticals Business Overview
  10. 6.2.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio
  12. 6.2.5 Mylan Pharmaceuticals Recent Developments
  13. 6.3 Hetero
  14. 6.3.1 Hetero Company Information
  15. 6.3.2 Hetero Business Overview
  16. 6.3.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hetero Atovaquone and Proguanil Product Portfolio
  18. 6.3.5 Hetero Recent Developments
  19. 6.4 Glenmark
  20. 6.4.1 Glenmark Company Information
  21. 6.4.2 Glenmark Business Overview
  22. 6.4.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark Atovaquone and Proguanil Product Portfolio
  24. 6.4.5 Glenmark Recent Developments
7 North America by Country
  1. 7.1 North America Atovaquone and Proguanil Sales by Country
  2. 7.1.1 North America Atovaquone and Proguanil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Atovaquone and Proguanil Sales by Country (2021-2026)
  4. 7.1.3 North America Atovaquone and Proguanil Sales Forecast by Country (2027-2032)
  5. 7.2 North America Atovaquone and Proguanil Market Size by Country
  6. 7.2.1 North America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Atovaquone and Proguanil Market Size by Country (2021-2026)
  8. 7.2.3 North America Atovaquone and Proguanil Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Atovaquone and Proguanil Sales by Country
  2. 8.1.1 Europe Atovaquone and Proguanil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Atovaquone and Proguanil Sales by Country (2021-2026)
  4. 8.1.3 Europe Atovaquone and Proguanil Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Atovaquone and Proguanil Market Size by Country
  6. 8.2.1 Europe Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Atovaquone and Proguanil Market Size by Country (2021-2026)
  8. 8.2.3 Europe Atovaquone and Proguanil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Atovaquone and Proguanil Sales by Country
  2. 9.1.1 Asia-Pacific Atovaquone and Proguanil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Atovaquone and Proguanil Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Atovaquone and Proguanil Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Atovaquone and Proguanil Market Size by Country
  6. 9.2.1 Asia-Pacific Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Atovaquone and Proguanil Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Atovaquone and Proguanil Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Atovaquone and Proguanil Sales by Country
  2. 10.1.1 South America Atovaquone and Proguanil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Atovaquone and Proguanil Sales by Country (2021-2026)
  4. 10.1.3 South America Atovaquone and Proguanil Sales Forecast by Country (2027-2032)
  5. 10.2 South America Atovaquone and Proguanil Market Size by Country
  6. 10.2.1 South America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Atovaquone and Proguanil Market Size by Country (2021-2026)
  8. 10.2.3 South America Atovaquone and Proguanil Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Atovaquone and Proguanil Sales by Country
  2. 11.1.1 Middle East and Africa Atovaquone and Proguanil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Atovaquone and Proguanil Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Atovaquone and Proguanil Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Atovaquone and Proguanil Market Size by Country
  6. 11.2.1 Middle East and Africa Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Atovaquone and Proguanil Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Atovaquone and Proguanil Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Atovaquone and Proguanil Value Chain Analysis
  2. 12.1.1 Atovaquone and Proguanil Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Atovaquone and Proguanil Production Mode & Process
  7. 12.2 Atovaquone and Proguanil Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Atovaquone and Proguanil Distributors
  10. 12.2.3 Atovaquone and Proguanil Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst